Looking at the legal issues surrounding placental abruption, amniocentesis, cerebral palsy, bowel perforation, incontinence, and necrotizing fasciitis.
The patient sued those involved with the delivery, claiming negligence in that the U/S equipment was old, the wrong type of transducer was used, and an U/S technician more familiar with using more advanced U/S equipment should have been available immediately.
The physician argued that he was certain that the fetal heart had stopped when he performed the U/S and that the heart had started again by the time the U/S technician found a heartbeat.
The jury in this case found no negligence on the part of the physician, but did find that the hospital was at fault for not providing up-to-date equipment and not having skilled personnel to perform an emergency U/S in a timely manner. The jury awarded a total of $78.5 million, which included $1.5 million in emotional distress for the mother, $10 million in pain and suffering for the child, $2 million in lost future earnings, and the rest in future medical expenses.
Complications after amniocentesis results in cerebral palsy
A VIRGINIA WOMAN was 33 weeks pregnant when she was found to have gestational diabetes. She was referred to an obstetrician who planned to induce labor 2 to 3 weeks early if the fetus grew too large, to reduce the risk of injury during delivery. An amniocentesis was done to check fetal lung maturity. A second obstetrician noted some abnormality of the fetal heart rate (FHR) following the procedure and directed the patient's family practitioner to induce labor and go ahead with delivery. The infant had seizures after delivery, was determined to have brain damage because of lack of oxygen, and had no kidney function. She has undergone 2 kidney transplants and has cerebral palsy. At time of trial she was aged 10 years and functioning at prekindergarten level.
In the lawsuit that followed the birth, the patient alleged that she was not fully informed of the risks and alternatives of the amniocentesis. She claimed that complications arose during the procedure and the physician failed to stop the amniocentesis and postpone the testing. She maintained that an immediate cesarean delivery should have been performed.
The defense denied any negligence, arguing that their care was an appropriate alternative plan to the actions the patient claimed should have been taken. A $9 million verdict was returned.
FDA grants 510(k) clearance to cobas liat STI multiplex assay panels
Published: January 22nd 2025 | Updated: January 22nd 2025The new panels, leveraging rapid polymerase chain reaction technology, allow point of care sexually transmitted infection diagnosis in 20 minutes, enhancing targeted treatment and reducing follow-up losses.
Read More
Study highlights need for interventions to prevent postpartum smoking relapse
January 21st 2025Smoking cessation during pregnancy not only reduces pregnancy complications but also lowers the risk of relapse and new smoking initiation in the first postpartum year, according to a recent study.
Read More
Timely surveillance reported in under half of HPV-positive patients
January 20th 2025A recent study highlights gaps in cervical cancer screening compliance, with fewer than 50% of human papillomavirus-positive, negative for intraepithelial lesion or malignancy patients receiving recommended follow-up testing within the guideline time frame.
Read More